These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 29414323)
21. Granulocytes and monocytes apheresis induces upregulation of TGFβ Contini P; Negrini S; Bodini G; Trucchi C; Ubezio G; Strada P; Savarino V; Ghio M J Clin Apher; 2017 Feb; 32(1):49-55. PubMed ID: 27080173 [TBL] [Abstract][Full Text] [Related]
22. THE INCIDENCE OF PRIMARY AND SECONDARY RESISTANCE TO THE ANTI-CYTOKINE THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE. Lazebnik LB; Sagynbaeva VE Eksp Klin Gastroenterol; 2016 Jul; 12(12):30-34. PubMed ID: 29889419 [TBL] [Abstract][Full Text] [Related]
24. Non-response to infliximab may be due to innate neutralizing anti-tumour necrosis factor-alpha antibodies. Ebert EC; Das KM; Mehta V; Rezac C Clin Exp Immunol; 2008 Dec; 154(3):325-31. PubMed ID: 18826498 [TBL] [Abstract][Full Text] [Related]
25. The role of granulocyte and monocyte apheresis in inflammatory bowel disease. Yamamoto T J Crohns Colitis; 2013 Apr; 7(3):e114. PubMed ID: 22868064 [No Abstract] [Full Text] [Related]
26. Adsorptive granulocyte and monocyte apheresis for refractory Crohn's disease: an open multicenter prospective study. Fukuda Y; Matsui T; Suzuki Y; Kanke K; Matsumoto T; Takazoe M; Matsumoto T; Motoya S; Honma T; Sawada K; Yao T; Shimoyama T; Hibi T J Gastroenterol; 2004 Dec; 39(12):1158-64. PubMed ID: 15622479 [TBL] [Abstract][Full Text] [Related]
27. Letter: immunogenicity of infliximab originator vs. CT-P13 in IBD patients. Fiorino G; Correale C; Radice S; Allocca M; Furfaro F; Gilardi D; Nagore D; Del Rio L; Pascual J; Martínez A; Danese S Aliment Pharmacol Ther; 2017 Nov; 46(9):903-905. PubMed ID: 29023889 [No Abstract] [Full Text] [Related]
28. Letter: immunogenicity of infliximab originator vs. CT-P13 in IBD patients-authors' reply. Komaki Y; Yamada A; Komaki F; Sakuraba A Aliment Pharmacol Ther; 2017 Nov; 46(9):905-906. PubMed ID: 29023885 [No Abstract] [Full Text] [Related]
29. [The application of selectie granulocyte and monocyte apheresis in the treatment of ulcerative colitis]. Liu ZF; Zheng HH; Jiang XL Zhonghua Nei Ke Za Zhi; 2017 Jun; 56(6):444-446. PubMed ID: 28592046 [No Abstract] [Full Text] [Related]
31. Evaluation of the effect of ulinastatin on the production of macrophage colony-stimulating factor in vitro for potential combination therapy with leukocyte adsorption. Nishise S; Takeda H; Orii T; Sato T; Sasaki Y; Nishise Y; Kawata S Ther Apher Dial; 2011 Aug; 15(4):379-84. PubMed ID: 21884473 [TBL] [Abstract][Full Text] [Related]
33. Granulocyte and monocyte adsorption apheresis for Behçet's disease in a pregnant woman. Higashi Y; Shimokawa M; Kawai K; Kanekura T J Dermatol; 2013 Dec; 40(12):1042-4. PubMed ID: 24303809 [TBL] [Abstract][Full Text] [Related]
34. Effect of an extract of the mushroom Agaricus blazei Murill on expression of adhesion molecules and production of reactive oxygen species in monocytes and granulocytes in human whole blood ex vivo. Bernardshaw S; Lyberg T; Hetland G; Johnson E APMIS; 2007 Jun; 115(6):719-25. PubMed ID: 17550380 [TBL] [Abstract][Full Text] [Related]
35. Efficacy of granulocyte/monocyte apheresis for moderate to severe Crohn's disease. Eaden JA; Ford AC Gut; 2013 Apr; 62(4):653. PubMed ID: 23019179 [No Abstract] [Full Text] [Related]
36. Is Adsorptive Granulocyte and Monocyte Apheresis Effective as an Alternative Treatment Option in Patients with Ulcerative Colitis? Jeon SR Gut Liver; 2017 Mar; 11(2):171-172. PubMed ID: 28274106 [No Abstract] [Full Text] [Related]
37. Leucocytapheresis for inflammatory bowel disease in the era of biologic therapy. Hanai H Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):596-600. PubMed ID: 18679059 [TBL] [Abstract][Full Text] [Related]
38. [The cytokines in inflammatory bowel disease]. Polińska B; Matowicka-Karna J; Kemona H Postepy Hig Med Dosw (Online); 2009 Aug; 63():389-94. PubMed ID: 19724079 [TBL] [Abstract][Full Text] [Related]
39. Granulocyte and monocyte adsorption apheresis for paradoxical reaction to infliximab. Arimura A; Hatanaka M; Katsue H; Matsushita S; Kanekura T J Dermatol; 2015 Apr; 42(4):438-9. PubMed ID: 25655018 [No Abstract] [Full Text] [Related]
40. Immunoregulatory effects of adsorptive granulocyte and monocyte apheresis in patients with drug refractory Crohn's disease. Nagase K; Fukunaga K; Kashiwamura S; Kono T; Kamikozuru K; Yokoyama Y; Hida N; Ohda Y; Takeda N; Yoshida K; Iimuro M; Kikuyama R; Kato K; Miwa H; Matsumoto T Ther Apher Dial; 2011 Aug; 15(4):367-73. PubMed ID: 21884471 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]